Page 138 - Medicinal Chemistry Self Assessment
P. 138

Part 2 ANSWERS
















                                                                  Section 4 – Whole Molecule Drug

                                                                  Evaluation

                                                                  2.8    Aliskiren .................................................................... 129
                                                                  2.9    Aripiprazole ............................................................... 137
                                                                  2.10  Cefprozil .................................................................... 143
                                                                  2.11  Cetirizine ................................................................... 149
                                                                  2.12  Chlorpropamide and Other Sulfonylureas ................. 153
                                                                  2.13  Dabigatran Etexilate ................................................. 159
                                                                  2.14  Fenofibrate and Gemfibrozil ...................................... 165
                                                                  2.15  Fluvoxamine .............................................................. 169
                                                                  2.16  Haloperidol ............................................................... 173
                                                                  2.17  Hydrocortisone .......................................................... 177
                                                                  2.18  Levothyroxine (T ) ..................................................... 183
                                                                                   4
                                                                  2.19  Lidocaine ................................................................... 189
                                                                  2.20  Montelukast and Zafirlukast ..................................... 193







                                                                  2.21  Phenobarbital and Other Barbiturates ...................... 199
                                                                  2.22  Pravastatin and Fluvastatin ....................................... 205
                                                                  2.23  Quinapril ................................................................... 211
                                                                  2.24  Rivastigmine ............................................................. 217
                                                                  2.25  Sitagliptin .................................................................. 223
                                                                  2.26  Sorafenib ................................................................... 227
                                                                  2.27  Zanamivir and Oseltamivir ........................................ 233
   133   134   135   136   137   138   139   140   141   142   143